| Pathways |
|
|
|
|
|
|
| Serotonin degradation |
↑ |
|
|
|
|
↑ |
| Ethanol degradation II |
↑ |
|
|
|
|
|
| Synaptic long-term depression |
↑ |
|
|
|
|
|
| Noradrenaline and adrenaline degradation |
↑ |
|
|
|
|
|
| Sperm motility |
↑ |
|
|
|
|
|
| Phospholipases |
↑ |
|
|
|
|
|
| LXR/RXR activation |
↑ |
|
|
|
|
↑ |
| Fatty acid β-oxidation I |
↑ |
|
|
↑ |
|
↑ |
| Nicotine degradation II |
↑ |
|
|
|
↑ |
↑ |
| eNOS signaling |
↑ |
|
|
|
|
|
| Leukocyte extravasation signaling |
↑ |
↑ |
↑ |
|
|
|
| p70S6K signaling |
↑ |
|
|
|
|
|
| Retinol biosynthesis |
↑ |
|
|
|
|
|
| Stearate biosynthesis I (animals) |
↑ |
|
|
↑ |
|
|
| Histamine degradation |
↑ |
|
|
|
|
|
| Aldosterone signaling in epithelial cells |
↑ |
|
|
|
|
|
| HIPPO signaling |
↑ |
|
|
|
|
|
| cAMP-mediated signaling |
↑ |
|
|
|
|
|
| Synaptic long-term potentiation |
↑ |
|
|
|
|
|
| Fcγ receptor-mediated phagocytosis in macrophages and monocytes |
↑ |
|
↑ |
|
|
|
| IL-8 signaling |
|
↑ |
↑ |
|
|
|
| Rac signaling |
|
|
↑ |
|
|
|
| NF-κB activation by viruses |
|
|
↑ |
|
|
|
| Salvage pathways of pyrimidine ribonucleotides |
|
|
↑ |
|
|
|
| Gαq signaling |
|
|
↑ |
|
|
|
| Pyridoxal 5′-phosphate salvage pathway |
|
|
↑ |
|
|
|
| GP6 signaling pathway |
|
|
↑ |
|
|
|
| Colorectal cancer metastasis signaling |
|
|
↑ |
|
|
|
| ILK signaling |
|
|
↑ |
|
|
|
| Integrin signaling |
|
|
↑ |
|
|
|
| mTOR signaling |
|
|
↑ |
|
|
|
| Phospholipase C signaling |
|
|
↑ |
|
|
|
| Cardiac hypertrophy signaling (enhanced) |
|
↑ |
↑ |
|
|
|
| ERK5 signaling |
|
|
↑ |
|
|
|
| Sphingosine-1-phosphate signaling |
|
|
↑ |
|
|
|
| Small cell lung cancer signaling |
|
|
↑ |
|
|
|
| Gα12/13 signaling |
|
|
↑ |
|
|
|
| Signaling by rho family GTPases |
|
|
↑ |
|
|
|
| Superpathway of cholesterol biosynthesis |
|
|
|
|
↑ |
|
| PPAR signaling |
|
|
|
|
|
|
| Nicotine degradation III |
|
|
|
|
↑ |
|
| Melatonin degradation I |
|
|
|
|
|
|
| Superpathway of melatonin degradation |
|
|
|
|
|
|
| Xenobiotic metabolism CAR signaling pathway |
|
|
|
|
|
|
| Xenobiotic metabolism PXR signaling pathway |
|
|
|
|
|
|
| Cholesterol biosynthesis I |
|
|
|
|
↑ |
|
| Cholesterol biosynthesis II (via 24,25-dihydrolanosterol) |
|
|
|
|
|
|
| Cholesterol biosynthesis III (via desmosterol) |
|
|
|
|
↑ |
|
